Literature DB >> 20458023

Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.

Mandip S Dhamoon1, Mitchell S V Elkind.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20458023      PMCID： PMC2907739          DOI： 10.1161/CIRCULATIONAHA.109.921072

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  38 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

4.  Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease.

Authors:  Barbara G Vickrey; Thomas S Rector; Steven L Wickstrom; Peter M Guzy; Elizabeth M Sloss; Philip B Gorelick; Steven Garber; Daniel F McCaffrey; Michael D Dake; Regina A Levin
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

5.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

6.  Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.

Authors:  Pierre Amarenco; Oscar Benavente; Larry B Goldstein; Alfred Callahan; Henrik Sillesen; Michael G Hennerici; Steve Gilbert; Amy E Rudolph; Lisa Simunovic; Justin A Zivin; K Michael A Welch
Journal:  Stroke       Date:  2009-02-19       Impact factor: 7.914

7.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

8.  The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.

Authors:  Arash Rashidi; Ashwini Reddi Sehgal; Mahboob Rahman; Andrew Stenson O'Connor
Journal:  Am J Cardiol       Date:  2008-10-23       Impact factor: 2.778

9.  Telmisartan to prevent recurrent stroke and cardiovascular events.

Authors:  Salim Yusuf; Hans-Christoph Diener; Ralph L Sacco; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  N Engl J Med       Date:  2008-08-27       Impact factor: 91.245

10.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16
View more
  10 in total

1.  Statin underuse and low prevalence of LDL-C control among U.S. adults at high risk of coronary heart disease.

Authors:  Christopher M Gamboa; Monika M Safford; Emily B Levitan; Devin M Mann; Huifeng Yun; Stephen P Glasser; J Michael Woolley; Robert Rosenson; Michael Farkouh; Paul Muntner
Journal:  Am J Med Sci       Date:  2014-08       Impact factor: 2.378

2.  The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study.

Authors:  Mandip S Dhamoon; Yeseon Park Moon; Myunghee C Paik; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2011-08-18       Impact factor: 7.914

Review 3.  Cardiovascular Events After Intracerebral Hemorrhage.

Authors:  Linxin Li; Santosh B Murthy
Journal:  Stroke       Date:  2022-06-08       Impact factor: 10.170

4.  Psychological and social support associations with mortality and cardiovascular disease in middle-aged American Indians: the Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Harry Eyituoyo; Marcia O'Leary; Shelley A Cole; Aminata Traore; Steve Verney; Barbara Howard; Spero Manson; Dedra Buchwald; Paul Whitney
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-02-14       Impact factor: 4.519

5.  Authors' reply.

Authors:  Sandeep Chopra; Soumia Peter
Journal:  Indian J Endocrinol Metab       Date:  2012-05

6.  Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.

Authors:  Hermann Toplak; Bernhard Ludvik; Monika Lechleitner; Hans Dieplinger; Bernhard Föger; Bernhard Paulweber; Thomas Weber; Bruno Watschinger; Sabine Horn; Thomas C Wascher; Heinz Drexel; Marianne Brodmann; Ernst Pilger; Alexander Rosenkranz; Erich Pohanka; Rainer Oberbauer; Otto Traindl; Franz Xaver Roithinger; Bernhard Metzler; Hans-Peter Haring; Stefan Kiechl
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

7.  Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.

Authors:  Adam P Bress; Rikki M Tanner; Rachel Hess; Samuel S Gidding; Lisandro D Colantonio; Daichi Shimbo; Paul Muntner
Journal:  J Am Heart Assoc       Date:  2016-07-12       Impact factor: 5.501

8.  Coronary Artery Calcium Score Improves the Prediction of Occult Coronary Artery Stenosis in Ischemic Stroke Patients.

Authors:  Ysoline Beigneux; Jean-Louis Sablayrolles; Olivier Varenne; Jean-Louis Mas; David Calvet
Journal:  J Am Heart Assoc       Date:  2016-10-31       Impact factor: 5.501

9.  Incidence of Acute Myocardial Infarction in Patients Presenting With Cerebrovascular Accident in a Tertiary Care Centre in Eastern India.

Authors:  Jaymala Mishra; Abhay Kumar; Santosh Kumar; Siddharth Singh; Santosh Kumar Nayan; Anand Dev
Journal:  Cureus       Date:  2022-09-10

10.  Quantifying the risk of heart disease following acute ischaemic stroke: a meta-analysis of over 50,000 participants.

Authors:  Trishna Gunnoo; Nazeeha Hasan; Muhammad Saleem Khan; Julia Slark; Paul Bentley; Pankaj Sharma
Journal:  BMJ Open       Date:  2016-01-20       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.